China SXT Pharmaceuticals, Inc. Cash and Restricted Cash
China SXT Pharmaceuticals, Inc. (SXTC) had Cash and Restricted Cash of $28.18 million as of 2026-03-31, per its 20-F filed 2026-07-01.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-07-01
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $28.18M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $21.20M.
- 2025-04-01: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $18.13M.
- 2025-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $18.13M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-03-31 | $28.18M 20-F · filed 2026-07-01 |
| 2025-09-30 | $21.20M 6-K · filed 2025-12-31 |
| 2025-04-01 | $18.13M 20-F · filed 2026-07-01 |
| 2025-03-31 | $18.13M 20-F · filed 2026-07-01 |
| 2024-09-30 | $18.51M 6-K · filed 2025-12-31 |
| 2024-04-01 | $12.08M 20-F · filed 2026-07-01 |
| 2024-03-31 | $12.08M 20-F · filed 2026-07-01 |
| 2023-09-30 | $11.47M 6-K · filed 2025-03-28 |
| 2023-04-01 | $17.37M 20-F · filed 2026-07-01 |
| 2023-03-31 | $17.37M 20-F · filed 2025-07-31 |
| 2022-09-30 | $2.98M 6-K · filed 2024-04-05 |
| 2022-03-31 | $15.57M 20-F · filed 2025-07-31 |
| 2021-09-30 | $31.32K 6-K · filed 2023-02-24 |
| 2021-03-31 | $13.36M 20-F · filed 2024-08-13 |
| 2020-09-30 | $10.35M 6-K · filed 2022-01-14 |
| 2020-03-31 | $7.29M 20-F · filed 2023-07-31 |
| 2019-09-30 | $8.32M 6-K · filed 2021-01-28 |
| 2019-03-31 | $9.29M 20-F/A · filed 2023-05-19 |